RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nextgen Biomed Stock

Nextgen Biomed ROA 2025

Nextgen Biomed ROA

0

Ticker

NXGN.TA

ISIN

IL0010839301

In 2025, Nextgen Biomed's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Nextgen Biomed Aktienanalyse

What does Nextgen Biomed do?

Nextgen Biomed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Nextgen Biomed's Return on Assets (ROA)

Nextgen Biomed's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Nextgen Biomed's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Nextgen Biomed's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Nextgen Biomed’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Nextgen Biomed stock

What is the Return on Assets (ROA) of Nextgen Biomed this year?

The Return on Assets (ROA) of Nextgen Biomed is 0 undefined this year.

What was the ROA of Nextgen Biomed compared to the previous year?

The ROA of Nextgen Biomed has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Nextgen Biomed?

A high ROA is advantageous for investors of Nextgen Biomed, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Nextgen Biomed?

A low ROA can be unfavorable for investors of Nextgen Biomed as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Nextgen Biomed affect the company?

An increase in ROA of Nextgen Biomed can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Nextgen Biomed impact the company?

A reduction in the ROA of Nextgen Biomed can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Nextgen Biomed?

Some factors that can influence the ROA of Nextgen Biomed include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Nextgen Biomed important for investors?

The ROA of Nextgen Biomed is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Nextgen Biomed take to improve ROA?

To improve ROA, Nextgen Biomed can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Nextgen Biomed pay?

Over the past 12 months, Nextgen Biomed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nextgen Biomed is expected to pay a dividend of 0 ILS.

What is the dividend yield of Nextgen Biomed?

The current dividend yield of Nextgen Biomed is .

When does Nextgen Biomed pay dividends?

Nextgen Biomed pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nextgen Biomed?

Nextgen Biomed paid dividends every year for the past 0 years.

What is the dividend of Nextgen Biomed?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nextgen Biomed located?

Nextgen Biomed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nextgen Biomed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nextgen Biomed from 2/7/2025 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 2/7/2025.

When did Nextgen Biomed pay the last dividend?

The last dividend was paid out on 2/7/2025.

What was the dividend of Nextgen Biomed in the year 2024?

In the year 2024, Nextgen Biomed distributed 0 ILS as dividends.

In which currency does Nextgen Biomed pay out the dividend?

The dividends of Nextgen Biomed are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nextgen Biomed

Our stock analysis for Nextgen Biomed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nextgen Biomed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.